We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$4.72B
AUM Growth
+$129M
Cap. Flow
-$61M
Cap. Flow %
-1.29%
Top 10 Hldgs %
31.68%
Holding
1,068
New
22
Increased
398
Reduced
603
Closed
42

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$7.82M
2
D icon
Dominion Energy
D
+$7.55M
3
EL icon
Estee Lauder
EL
+$7.22M
4
CDW icon
CDW
CDW
+$6.93M
5
MNST icon
Monster Beverage
MNST
+$6.78M

Top Sells

Rank Stock Value
1
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$10.6M
2
AAPL icon
Apple
AAPL
+$10.3M
3
WMT icon
Walmart Inc
WMT
+$6.86M
4
RTX icon
RTX Corp
RTX
+$6.78M
5
IBM icon
IBM
IBM
+$6.07M

Sector Composition

Rank Sector Weight
1 Technology 29.87%
2 Consumer Discretionary 13.88%
3 Healthcare 13.22%
4 Financials 11.48%
5 Communication Services 10.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BA icon
76
Boeing
BA
$166B
$11.3M 0.24%
44,227
+487
+1% +$108K
RF icon
77
Regions Financial
RF
$25.9B
$11.2M 0.24%
543,876
+3,657
+0.7% +$71.5K
CDW icon
78
CDW
CDW
$18.6B
$11.2M 0.24%
67,414
+46,448
+222% +$6.93M
EW icon
79
Edwards Lifesciences
EW
$51.8B
$11.1M 0.24%
132,703
+41,596
+46% +$3.52M
CAT icon
80
Caterpillar
CAT
$376B
$11M 0.23%
47,507
+23,980
+102% +$4.96M
D icon
81
Dominion Energy
D
$58.5B
$10.9M 0.23%
143,561
+104,004
+263% +$7.55M
CVS icon
82
CVS Health
CVS
$119B
$10.7M 0.23%
141,638
+77
+0.1% +$5.61K
PLD icon
83
Prologis
PLD
$135B
$10.6M 0.22%
99,723
+13
+0% +$1.32K
IDXX icon
84
Idexx Laboratories
IDXX
$42.9B
$10.4M 0.22%
21,235
+8,856
+72% +$4.44M
ETN icon
85
Eaton
ETN
$162B
$10.3M 0.22%
74,552
-143
-0.2% -$18.4K
NEE icon
86
NextEra Energy
NEE
$174B
$10.3M 0.22%
136,173
-1,070
-0.8% -$83.5K
ZTS icon
87
Zoetis
ZTS
$31B
$10.3M 0.22%
65,112
-198
-0.3% -$31.4K
ATVI
88
DELISTED
Activision Blizzard
ATVI
$10.2M 0.22%
109,856
+355
+0.3% +$33.4K
CCI icon
89
Crown Castle
CCI
$31.9B
$10.1M 0.21%
58,725
-310
-0.5% -$49.7K
TJX icon
90
TJX Companies
TJX
$148B
$10.1M 0.21%
152,517
-45,271
-23% -$3.03M
MS icon
91
Morgan Stanley
MS
$337B
$9.89M 0.21%
127,343
+2,714
+2% +$208K
GE icon
92
GE Aerospace
GE
$356B
$9.87M 0.21%
150,771
-718
-0.5% -$43.5K
MET icon
93
MetLife
MET
$61.2B
$9.83M 0.21%
161,765
-139
-0.1% -$7.67K
GS icon
94
Goldman Sachs
GS
$303B
$9.68M 0.21%
29,616
-81
-0.3% -$25.2K
SNPS icon
95
Synopsys
SNPS
$89B
$9.56M 0.2%
38,583
+84
+0.2% +$21.3K
HIG icon
96
Hartford Financial Services
HIG
$37.3B
$9.29M 0.2%
139,044
+719
+0.5% +$38.8K
SHW icon
97
Sherwin-Williams
SHW
$83.8B
$8.89M 0.19%
36,120
-11,775
-25% -$2.81M
EQIX icon
98
Equinix
EQIX
$106B
$8.87M 0.19%
13,053
-48
-0.4% -$32.9K
SCHW
99
Charles Schwab
SCHW
$187B
$8.87M 0.19%
136,030
+173
+0.1% +$10.5K
DHR icon
100
Danaher
DHR
$152B
$8.82M 0.19%
44,183
-159
-0.4% -$32.3K

Similar funds

Xponance's Q1 2021 Portfolio in Review

As of Q1 2021, Xponance held 1,068 positions worth $4.72B, up 2.8% from $4.59B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Xponance's Q1 2021 filing shows 22 new, 398 increased, 603 reduced and 42 closed positions. Its largest new stake was NXP Semiconductors: 11,727 shares worth $2.36M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $10.6M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q1 2021 buy was NXP Semiconductors: 11,727 shares worth $2.36M.
  • Xponance added most to Visa in Q1 2021, an estimated $7.82M increase.
  • Xponance's biggest Q1 2021 reduction was Apple, cutting an estimated $10.3M.
  • Xponance fully exited iShares Core MSCI Emerging Markets ETF in Q1 2021, selling an estimated $10.6M.
  • Xponance's ten largest holdings make up 32% of its $4.72B portfolio in Q1 2021.
  • Xponance opened 22 new positions and closed 42 in Q1 2021.
  • Xponance's portfolio value rose 2.8% quarter-over-quarter to $4.72B.

Based on Xponance's 13F filing for Q1 2021, filed 10 May 2021.